Treatment of Liver Cirrhosis with a First Episode of Grade 2 (Moderate) Ascites

A first episode of grade 2 (moderate) ascites in a patient with liver cirrhosis represents a defined clinical scenario with specific, evidence-based management targets. The approach balances fluid reduction with patient safety.

Clinical Scenario

The patient has liver cirrhosis and presents with a first episode of grade 2 (moderate) ascites. This is a first-line situation — no prior treatment for ascites has been used.

Approach (Partial Overview)

Management centres on moderate dietary sodium restriction combined with an anti-mineralocorticoid agent, titrated stepwise according to response. The complete starting dose, escalation schedule, and maximum dose are detailed in the full protocol.

Treatment Goals

Response is assessed by the rate of body weight reduction per week. Safe daily weight-loss limits apply and differ depending on whether peripheral oedema is present. The full numeric targets are specified in the protocol.

Instant Access to Structured Evidence-Based Regimens

References

A moderate restriction of sodium intake (80–120 mmol/day, corresponding to 4.6–6.9 g of salt) is recommended in patients with moderate, uncomplicated ascites (I;1).
Patients with the first episode of grade 2 (moderate) ascites should receive an anti-mineralocorticoid drug alone, starting at 100 mg/day with stepwise increases every 72 h (in 100 mg steps) to a maximum of 400 mg/day if there is no response to lower doses (I;1).
During diuretic therapy a maximum weight loss of 0.5 kg/day in patients without oedema and 1 kg/day in patients with oedema is recommended (II-2;1).

DOI: 10.1016/j.jhep.2018.03.024

View source ↗